98%
921
2 minutes
20
Purpose: Serial casting limits curve progression while preserving spinal growth, delaying or even eliminating the need for surgery. Some patients with EOIS can be "cured" with curve reduction under 15°. However, no long-term studies have defined whether "cured" patients maintain small curves or if they are at risk of progression. We examined if casting patients remained "cured" following treatment.
Methods: We identified 40 EOIS patients who were treated with serial casting, achieved curves under 15° and had minimum 2 years of follow-up after completing the treatment. Failure was defined as an increase > 6° resulting in a curve magnitude > 15° at any point during follow-up, requiring cast/brace treatment after cessation of initial cast/brace, or undergoing surgery. Average curve magnitude at the time of cure was 11.1°. Kaplan-Meier survival analysis was used to identify failure rates over time.
Results: 10 patients (25.0%) met criteria for failure. Mean time from cure to last follow-up was 4.3 years. 3 patients (7.5%) completed bracing and were later re-braced while 2 (5.0%) required surgery. Mean curve magnitude of "failed" patients was 27.4° with an average increase of 15.6°. At 5.1 years, probability of successful treatment is 64.2%. For "failed" patients, median time to failure was 2.4 years. Successful patients were braced for median 1.4 years, while "failed" patients had a median of 1 year.
Conclusion: While EOIS patients may be "cured" with serial casting, this may not be sustained. The percentage of "failures" likely will increase with longer follow-up through skeletal maturity, and patients must be closely monitored after concluding casting/bracing.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401748 | PMC |
http://dx.doi.org/10.1007/s43390-025-01092-1 | DOI Listing |
Pediatr Phys Ther
September 2025
Hillsboro, Oregon (Dr Quinn); Oregon Health & Science University, Portland, Oregon (Dr Sloane).
Purpose: This case report describes the combined use of whole-body vibration (WBV), serial casting (SC), and physical therapy (PT) for a child with hemiplegic cerebral palsy (HCP).
Summary Of Key Points: A 3-year 10-month-old male with HCP was followed for 10 months. Treatment included 9 weeks of SC due to ankle plantarflexion contracture, hypertonicity, poor orthotic tolerance, and gait limitations.
Cureus
July 2025
Pediatrics, University of Florida College of Medicine, Gainesville, USA.
Congenital knee dislocation (CKD) is a rare condition that can present as an isolated finding or in association with genetic syndromes. It is most commonly diagnosed postnatally and classified into three grades based on severity. While generally having a favorable prognosis, particularly for milder cases, prompt treatment is crucial.
View Article and Find Full Text PDFEur J Case Rep Intern Med
July 2025
Department of Nephrology, University Hospital Marie-Curie, Charleroi, Belgium.
Introduction: Bile cast nephropathy (BCN) is a rare and often overlooked cause of acute kidney injury (AKI), usually seen in the context of severe hyperbilirubinemia. It results from the deposition of bile pigments and bile casts in renal tubules, specifically distal and collector tubules, leading to obstruction and direct tubular toxicity.
Case Description: We describe the case of 49-year-old male who presented with severe jaundice and oliguric AKI.
Front Neurol
July 2025
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
[This corrects the article DOI: 10.3389/fneur.2025.
View Article and Find Full Text PDFDrug Deliv Transl Res
July 2025
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
Oral ulcerative mucositis (OUM) is a common painful disease that affects oral functions, such as eating or speaking leading to a low quality of life. This study aims to develop a novel strategy for relieving pain associated with OUM by using local anesthetics. Here, a hybrid dissolving microneedle patch integrated with lidocaine (Lido)-encapsulated invasomes (modified liposomes containing terpenes as penetration enhancers) depots are introduced for sustained Lido delivery, reduced dosing frequency, and improved patient compliance.
View Article and Find Full Text PDF